Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
AstraZeneca’s Calquence Study: Evaluating Safety in Real-World CLL Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
Pfizer’s New Phase 1 Study: A Potential Breakthrough in Cancer Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting an open-label Phase...
10h ago
PFE
AstraZeneca’s New Study on Trastuzumab Deruxtecan: Potential Market Impact
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
Pfizer’s Promising Study on Disitamab Vedotin for Advanced Breast Cancer
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a...
10h ago
PFE
Edwards Lifesciences’ Pivotal Trial: A Game-Changer for Tricuspid Valve Repair?
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is...
10h ago
EW
OSE Immunotherapeutics Advances in NSCLC Treatment with Phase 3 Trial of OSE2101
DEL_OSE Immunotherapeutics (($DEL_0RAD)), OSE Immunotherapeutics (($DE:6OP)) announced an update on their ongoing clinical study. OSE Immunotherapeutics has initiated...
10h ago
Compass Pathways’ Psilocybin Study: A Potential Game-Changer for Depression Treatment
Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a...
10h ago
CMPS
AstraZeneca’s COPD Study: Potential Market Impact of New Inhaler Treatments
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
MacroGenics Inc (($MGNX)) announced an update on their ongoing clinical study. Study Overview: MacroGenics Inc. is conducting a...
10h ago
MGNX
Almirall’s Phase 3 Study on Tirbanibulin for Actinic Keratosis: Key Insights for Investors
Almirall SA (($GB:0O9B)), Almirall (($DE:E2Z)) announced an update on their ongoing clinical study. Almirall S.A. has completed a...
10h ago
Bristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis Drug
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting...
10h ago
BMY
AstraZeneca’s New Study on Volrustomig: A Potential Breakthrough in Cervical Cancer Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
GSK’s Belimumab Study: A Potential Game-Changer for Early SLE Treatment
GlaxoSmithKline (($GSK)), GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is currently...
10h ago
GSK
Bristol-Myers Squibb and Pfizer’s Promising Study in Multiple Myeloma Treatment
Bristol-Myers Squibb Company (($BMY)), Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers...
10h ago
BMY
PFE
AstraZeneca’s Nexium Study: Potential Market Game-Changer for Pediatric Erosive Esophagitis
Medidata Solutions (($MDSO)), AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on...
10h ago
AZN
MDSO
Pfizer’s New Cancer Treatment Trial: A Potential Game-Changer?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical trial...
10h ago
PFE
Sanofi’s Asthma Study: Long-term Safety and Efficacy of Lunsekimig
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi has launched...
10h ago
SNY
Pfizer’s New Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has initiated a Phase 3...
10h ago
PFE
Eli Lilly’s New Study on LY4088044: What Investors Need to Know
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
10h ago
LLY
Silk Road Medical’s ROADSTER 3 Study Update: Long-Term Outcomes in Focus
Silk Road Medical (($SILK)) announced an update on their ongoing clinical study. Study Overview: The ROADSTER 3 Extended...
10h ago
SILK
Gilead Sciences’ TAF Study in Children with Hepatitis B: An Update
Gilead Sciences (($GILD)), Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. The recent update from...
10h ago
GILD
Regeneron and Sanofi’s New COPD Study: Key Insights for Investors
Regeneron Pharmaceuticals (($REGN)), Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study....
10h ago
SNY
REGN
X4 Pharmaceuticals Advances Phase 3 Study of Mavorixafor for WHIM Syndrome
X4 Pharmaceuticals (($XFOR)) announced an update on their ongoing clinical study. Study Overview: X4 Pharmaceuticals is conducting a...
10h ago
XFOR
AstraZeneca’s ROSY-O Study: Extending Benefits of Olaparib for Oncology Patients
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
Pfizer’s Phase 3 Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3...
10h ago
PFE
Sanofi’s Gene Therapy Study for Phenylketonuria: A Potential Game Changer
Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting...
10h ago
SNY
AbbVie’s Upadacitinib Study Completion: A Potential Game-Changer for Atopic Dermatitis Treatment
Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has completed a clinical study...
10h ago
ABBV
AbbVie Explores New Horizons in Multiple Myeloma Treatment with ABBV-453 Study
Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 1/2...
10h ago
ABBV
AstraZeneca’s LYNPARZA Study: Key Insights for Investors
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
10h ago
AZN
Pfizer’s COVID-19 Vaccine Study Completes: Implications for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has completed a study titled...
10h ago
PFE
Pfizer’s Elranatamab Study: A Continued Hope for Multiple Myeloma Patients
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
10h ago
PFE
Pfizer’s Latest Study on HER2-positive Breast Cancer: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
10h ago
PFE
Pfizer’s Phase 3 Study on Abrocitinib: A Potential Game-Changer for Atopic Dermatitis
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3...
10h ago
PFE
Pfizer’s New Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study...
10h ago
PFE
Bayer’s OASIS STAR Study: A New Look at Menopausal Treatment Patterns
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG has...
1d ago
AstraZeneca’s Phase 4 Study on Trastuzumab Deruxtecan: Safety Insights for Indian Patients
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
1d ago
AZN
AstraZeneca’s Innovative Study on Bladder Cancer: A Potential Game-Changer
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
1d ago
AZN
Bayer’s New Study on Nifurtimox: Implications for Investors
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG has...
1d ago
AstraZeneca’s NIAGARA-2 Study: A New Frontier in Bladder Cancer Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
1d ago
AZN
Bayer’s Finerenone Study: A Potential Game-Changer for Pediatric CKD Treatment
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG is...
1d ago
Bristol-Myers Squibb’s New NSCLC Study: A Potential Game-Changer?
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting...
1d ago
BMY
Bayer’s Darolutamide Study in India: A Potential Game-Changer for Prostate Cancer Treatment
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
1d ago
AstraZeneca’s Acalabrutinib Study: Real-World Insights for CLL Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
1d ago
AZN
AstraZeneca’s New Asthma Treatment Study Completes: Market Implications
AstraZeneca (($AZN)), Parexel International (($PRXL)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on...
1d ago
AZN
PRXL
GSK’s Long-Term Study on Atopic Dermatitis Drug: A Potential Game Changer?
GlaxoSmithKline (($GSK)), GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is conducting...
1d ago
GSK
Regeneron’s New Melanoma Treatment: A Game-Changer in the Making?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a...
1d ago
REGN
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
MacroGenics Inc (($MGNX)) announced an update on their ongoing clinical study. MacroGenics Inc. is conducting a clinical study...
1d ago
MGNX
Bayer’s New Prostate Cancer Study: A Potential Game-Changer?
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
1d ago
Bayer’s INFORM Study: Assessing Interferon-Beta Safety in Pregnancy
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG, in...
1d ago
Bayer’s Rivaroxaban Study: A Potential Game Changer for Pediatric Heart Patients
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG, in...
1d ago
SHOW MORE
You need to enable JavaScript to run this app.
